2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Systematic Assessment of 10 diagnostic marker candidates in biological fluids for Parkinson’s disease

B. Mollenhauer, R. Gera, N. Kruse, R. Barbour, W. Zago, S. Schade, B. Otte, C. Trenkwalder (South San Francisco, CA, USA)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: Systematic review of Mucuna Pruriens as a treatment for Parkinson’s disease

TH. Boonmongkol, O. Phokaewvarangkul, S. Vimolmangkang, R. Bhidayasiri (Bangkok, Thailand)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Targeted deep sequencing of brain DNA for detection of somatic point mutations in synucleinopathies

M. Leija-Salazar, A. Pittman, K. Mokretar, A. Schapira, C. Proukakis (London, United Kingdom)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Targeted NGS of genes related to hereditary and sporadic NDDs and movement disorders in Italian cohort

G. Dati, M. Picillo, M. Ginevrino, A. Vallelunga, MT. Pellecchia, EM. Valente, P. Barone (Baronissi, Italy)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: TELE PARK: Evaluation of the appropriation of a digitally guided self-rehabilitation device for patients with Parkinson’s disease and their professional entourage on a health territory in Brittany, France.

E. Leblong, AL. Roy, B. Fraudet, A. Riou, A. Durufle, JF. Aubry, B. Nicolas, P. Gallien (Rennes, France)

Physical and Occupational Therapy · Les Muses Terrace, Level 3

1:45pm-3:15pm: Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

F. Greblikas, HA. Jinnah, T. Klopstock, A. Videnovic, C. Burns (San Diego, CA, USA)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: Texas Biorepository of Human Induced Pluripotent Stem Cells for Studying Parkinson’s Disease

S. Wijemanne, H. Hong, G. Choudhury, J. Kim, J. Ramirez-Castaneda, A. Papanastassiou, M. Daadi (San Antonio, TX, USA)

Gene and Cell-Based Therapies · Les Muses Terrace, Level 3

1:45pm-3:15pm: TFEB-driven expression prevents neurodegeneration in a multiple system atrophy mouse model

ML. Arotcarena, M. Bourdenx, N. Dutheil, ML. Thiolat, E. Doudnikoff, S. Dovero, A. Ballabio, PO. Fernagut, W. Meissner, E. Bezard, B. Dehay (Bordeaux, France)

Gene and Cell-Based Therapies · Les Muses Terrace, Level 3

1:45pm-3:15pm: The applicability of the Scale for Assessment and Rating of Ataxia (SARA) in toddlers

S. Polet, A. Tadema, S. Hbrahimgel, M. Vanden Berg, M. Kuiper, R. Brandsma, D. Sival (Groningen, Netherlands)

Ataxia · Les Muses, Level 3

1:45pm-3:15pm: The association parkinsonism and psychotic symptom in neurosyphilis

S. Nafia, N. Louhab, M. Chraa, N. Kissani (Marrakech, Morocco)

Psychiatric Manifestations · Les Muses Terrace, Level 3